CytoDyn Inc. Quarterly Common Stock, Shares, Issued from Q2 2011 to Q4 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
CytoDyn Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q2 2011 to Q4 2024.
  • CytoDyn Inc. Common Stock, Shares, Issued for the quarter ending November 30, 2024 was 1.22B shares, a 25.9% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 1.22B +252M +25.9% Nov 30, 2024 10-Q 2025-01-14
Q3 2024 1.22B +289M +31% Aug 31, 2024 10-Q 2024-10-15
Q2 2024 1.06B +140M +15.2% May 31, 2024 10-Q 2025-01-14
Q1 2024 990M +153M +18.3% Feb 29, 2024 10-Q 2024-04-15
Q4 2023 972M +146M +17.7% Nov 30, 2023 10-Q 2024-01-16
Q3 2023 931M +119M +14.6% Aug 31, 2023 10-Q 2023-10-23
Q2 2023 919M +199M +27.6% May 31, 2023 10-K 2024-08-15
Q1 2023 837M +123M +17.3% Feb 28, 2023 10-Q 2023-04-10
Q4 2022 825M +139M +20.3% Nov 30, 2022 10-Q 2023-01-09
Q3 2022 813M +169M +26.2% Aug 31, 2022 10-Q/A 2022-10-13
Q2 2022 720M +93.9M +15% May 31, 2022 10-K 2023-09-14
Q1 2022 714M +104M +17.1% Feb 28, 2022 10-Q 2022-04-11
Q4 2021 686M +95.6M +16.2% Nov 30, 2021 10-Q 2022-01-10
Q3 2021 644M +73.8M +12.9% Aug 31, 2021 10-Q 2021-10-12
Q2 2021 626M +622M +15553% May 31, 2021 10-K 2022-08-15
Q1 2021 609M +138M +29.4% Feb 28, 2021 10-Q 2021-04-14
Q4 2020 590M +191M +47.8% Nov 30, 2020 10-Q 2021-01-08
Q3 2020 570M +187M +48.7% Aug 31, 2020 10-Q 2020-10-09
Q2 2020 4M -326M -98.8% Jun 29, 2020 10-Q 2020-10-09
Q1 2020 471M +166M +54.6% Feb 29, 2020 10-Q 2020-04-09
Q4 2019 399M +109M +37.3% Nov 30, 2019 10-Q 2020-01-09
Q3 2019 384M +150M +64% Aug 31, 2019 10-Q 2019-10-08
Q2 2019 330M +113M +52% May 31, 2019 10-K 2020-08-14
Q1 2019 305M +95.8M +45.8% Feb 28, 2019 10-Q 2019-04-09
Q4 2018 291M +126M +76.1% Nov 30, 2018 10-Q 2019-01-09
Q3 2018 234M +81.1M +53.1% Aug 31, 2018 10-Q 2018-10-09
Q2 2018 217M +67.4M +45.1% May 31, 2018 10-K 2019-08-14
Q1 2018 209M +59.4M +39.8% Feb 28, 2018 10-Q 2018-04-09
Q4 2017 165M +26.9M +19.5% Nov 30, 2017 10-Q 2018-01-08
Q3 2017 153M +27.9M +22.3% Aug 31, 2017 10-Q 2017-10-10
Q2 2017 149M +26.1M +21.2% May 31, 2017 10-K 2018-07-27
Q1 2017 149M +31.1M +26.3% Feb 28, 2017 10-Q 2017-04-13
Q4 2016 138M +47.2M +51.8% Nov 30, 2016 10-Q 2017-01-13
Q3 2016 125M +45.3M +56.9% Aug 31, 2016 10-Q 2016-10-12
Q2 2016 123M 0 0% May 31, 2016 10-K 2017-07-20
Q1 2016 118M +59.1M +99.8% Feb 29, 2016 10-Q 2016-04-13
Q4 2015 91.1M +32.3M +55% Nov 30, 2015 10-Q 2016-01-11
Q3 2015 79.6M +23.9M +42.8% Aug 31, 2015 10-Q 2015-10-09
Q2 2015 123M +67.6M +121% May 31, 2015 10-K 2016-07-19
Q1 2015 59.3M +3.49M +6.26% Feb 28, 2015 10-Q 2015-04-10
Q4 2014 58.7M +3.2M +5.76% Nov 30, 2014 10-Q 2015-01-12
Q3 2014 55.8M +23.5M +72.9% Aug 31, 2014 10-Q 2014-10-10
Q2 2014 55.8M +24.8M +80.4% May 31, 2014 10-K 2015-07-10
Q1 2014 55.8M +24.8M +80.2% Feb 28, 2014 10-Q 2014-04-11
Q4 2013 55.5M +25.4M +84.5% Nov 30, 2013 10-Q 2014-01-13
Q3 2013 32.2M +2.14M +7.12% Aug 31, 2013 10-Q 2013-10-15
Q2 2013 30.9M +2.07M +7.19% May 31, 2013 10-K 2014-07-10
Q1 2013 30.9M +2.64M +9.32% Feb 28, 2013 10-Q 2013-04-12
Q4 2012 30.1M +7.62M +33.9% Nov 30, 2012 10-Q 2013-01-14
Q3 2012 30.1M +7.61M +33.8% Aug 31, 2012 10-Q/A 2012-11-08
Q2 2012 28.8M +6.35M +28.2% May 31, 2012 10-K 2013-08-29
Q1 2012 28.3M Feb 29, 2012 10-Q 2012-04-16
Q4 2011 22.5M Nov 30, 2011 10-Q 2012-01-17
Q3 2011 22.5M Aug 31, 2011 10-Q/A 2011-11-30
Q2 2011 22.5M May 31, 2011 10-K 2012-08-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.